Ospedale San Carlo di Nancy
Ospedale San Carlo di Nancy
Italy, Rome
Alessandro Calarco
19 years of experience
Clinic is certified :
| Italy | Turkey | Austria | |
| Removal of testicle tumor | - | from $4,500 | from $8,500 |
| Testicular prosthesis | - | from $1,500 | from $3,500 |
| Orchiectomy | - | from $2,570 | from $9,000 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Removal of testicle tumor upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Removal of testicle tumor and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Removal of testicle tumor journey.
Day 1 - Arrival
Day 2 - Pre-operation
Day 3 - Surgery
Day 4 - Post-operation
Week 1 - Rehabilitation
Week 2-4 - Rehabilitation continued
Week 5-8 - Final result
Please note that this is a general guide and individual experiences may vary. Always consult with your healthcare provider for personalized advice.
Dr. Caterina Lania specializes in male urogenital pathologies, including testicular tumors, with extensive research and clinical experience at San Raffaele Hospital.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.